Clinical Trial

Predicting Colorectal Cancer - Tissue Samples to Evaluate Tumour Characteristics and Treatment Response

Study acronym: Predict

Recruiting

Record status

This record was last updated November 7, 2023 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.

Summary

All adult patients with colorectal cancer presenting within the Sahlgrenska University Hospital or treated at any time at Sahlgrenska University Hospital are eligible and will be asked to participate. We already have biopsies taken at surgery in patients that receive surgery, but this study will include all patients and the biopsies will be taken during endoscopy for diagnosis of the primary tumour. Biopsies will then be taken during follow-up exams prior surgery but after neoadjuvant treatment. Biopsies will also be taken during surgery and in cases where surgery is not necessary biopsies will be taken regularly during follow-up exams. Blood samples and in relevant cases urinary samples and mouth swabs will be taken at all timepoints when biopsies are taken. If it is not possible to take biopsies prior treatment blood samples will still be drawn.

Protocol Amendment History 3 amendments

This ClinicalTrials.gov record has been amended 3 times since 2019-10-16; most recent amendment 2023-11-03.

Trial Details

NCT Number	NCT04130971
Lead Sponsor	Sahlgrenska University Hospital Collaborators: Göteborg University
Conditions	Colorectal Neoplasms
Enrollment	800 participants
Start Date	2019-02-01
Primary Completion	2025-12-31 (estimated)
Study Completion	2027-12-31 (estimated)
Updated on ClinicalTrials.gov	2023-11-07